Results 121 to 130 of about 51,886 (205)

No Effect of Immunogenicity on Pharmacokinetics, Efficacy, and Safety of the Oligonucleotide Telomerase Inhibitor Imetelstat in Lower-Risk Myelodysplastic Syndromes. [PDF]

Clin Transl Sci
Lennox AL, Huang F, González-Sales M, Wan Y, Sun L, Berry T, Feller F, Morcos PN.   +7 more
europepmc   +1 more source

Effective Management of Refractory Paraneoplastic Vasculitis in Myelodysplastic Syndromes With Azacitidine, Prednisolone, and Azathioprine. [PDF]

Case Rep Hematol
Takaba M, Nakano K, Yoda A, Otsuki Y, Fujisawa S.   +4 more
europepmc   +1 more source

A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in Lebanon [PDF]

, 2015
et al.,, Otrock, Zaher K
core   +1 more source

Burden of Myelodysplastic Syndromes: A Literature Review of Epidemiological and Humanistic Aspects. [PDF]

J Evid Based Med
Xie S, Yan J, Tse P, Humphries B, Xie F.
europepmc   +1 more source

Advances and challenges in the treatment of myelodysplastic syndromes. [PDF]

Exp Hematol Oncol
Thalla R, Mack R, Kosti-Schwartz J, Breslin P, Zhang J.   +4 more
europepmc   +1 more source

Development of Machine-Assisted, Human-Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes. [PDF]

EJHaem
Ogata K, Mochimaru Y, Saft L, Sijm G, Badaoui B, Alhan C, Almire C, Kato Y, Sakamoto D, Chiba N, Murata N, Kasai N, Sei K, Kawahara N, Ogata M, Chapuis N, Wagner-Ballon O, van de Loosdrecht A, Yamamoto Y.   +18 more
europepmc   +1 more source

Germline and somatic genetic landscape of pediatric myelodysplastic syndromes. [PDF]

Haematologica
Kotmayer L, Kennedy AL, Wlodarski MW.
europepmc   +1 more source

Advancing drug development in myelodysplastic syndromes. [PDF]

Blood Adv
Mina A, McGraw KL, Cunningham L, Kim N, Jen EY, Calvo KR, Ehrlich LA, Aplan PD, Garcia-Manero G, Foran JM, Garcia JS, Zeidan AM, DeZern AE, Komrokji R, Sekeres MA, Scott B, Buckstein R, Tinsley-Vance S, Verma A, Wroblewski T, Pavletic S, Norsworthy K.   +21 more
europepmc   +1 more source

Hotspot gene mutations and treatment response in myelodysplastic syndromes (MDS): predictive biomarkers and targeted strategies. [PDF]

Front Med (Lausanne)
Zhang R, Kou W, Wu T, Zhou R.
europepmc   +1 more source